Remove 2029 Remove Chemotherapy Remove Pharmaceutical Companies
article thumbnail

GlobalData forecasts ADC NSCLC market to reach $3.9 bn in 2032

Express Pharma

The ADC late development pipeline in NSCLC is active, with 29 Phase III ongoing global clinical trials sponsored by big pharmaceutical companies, including Merck & Co., AbbVie, AstraZeneca, and Daiichi Sankyo. 7MM: The US, France, Germany, Italy, Spain, the UK, and Japan.